Liver disease in pregnancy and fetal fatty acid oxidation defects
- PMID: 11001809
- DOI: 10.1006/mgme.2000.3065
Liver disease in pregnancy and fetal fatty acid oxidation defects
Abstract
Acute fatty liver of pregnancy (AFLP) and the syndrome of hemolysis, elevated liver enzymes, and low platelets (the HELLP syndrome) are serious disorders of the third trimester with high maternal and perinatal morbidity and mortality. Over the past decade, several clinical observations have demonstrated an association between these maternal syndromes and a recessively inherited fatty acid oxidation disorder, long chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency. Many women who carried LCHAD-deficient fetuses developed maternal liver disease. Over the past few years, we and others have made significant progress in understanding the molecular basis for this fetal-maternal interaction. Here, we review the studies in literature that led to the establishment of this causative association with particular emphasis on the molecular analysis that delineated the molecular basis of this association. The likely mechanisms for the genotype-phenotype correlations in pediatric LCHAD deficiency and the fetal-maternal interaction are discussed. Finally, the potential implications of our current knowledge for families with pediatric LCHAD deficiency and for women who develop AFLP and HELLP syndrome are discussed.
Copyright 2000 Academic Press.
Similar articles
-
Acute fatty liver of pregnancy, hemolysis, elevated liver enzymes, and low platelets syndrome, and long chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency.Am J Gastroenterol. 1996 Nov;91(11):2293-300. Am J Gastroenterol. 1996. PMID: 8931405
-
Fetal fatty acid oxidation defects and maternal liver disease in pregnancy.Obstet Gynecol. 2006 Jan;107(1):115-20. doi: 10.1097/01.AOG.0000191297.47183.bd. Obstet Gynecol. 2006. PMID: 16394048
-
A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women.N Engl J Med. 1999 Jun 3;340(22):1723-31. doi: 10.1056/NEJM199906033402204. N Engl J Med. 1999. PMID: 10352164
-
Inherited long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and a fetal-maternal interaction cause maternal liver disease and other pregnancy complications.Semin Perinatol. 1999 Apr;23(2):100-12. doi: 10.1016/s0146-0005(99)80044-5. Semin Perinatol. 1999. PMID: 10331463 Review.
-
Mitochondrial fatty acid oxidation and acute fatty liver of pregnancy.Semin Gastrointest Dis. 2002 Jan;13(1):55-66. Semin Gastrointest Dis. 2002. PMID: 11944635 Review.
Cited by
-
Role of 3-Hydroxy Fatty Acid-Induced Hepatic Lipotoxicity in Acute Fatty Liver of Pregnancy.Int J Mol Sci. 2018 Jan 22;19(1):322. doi: 10.3390/ijms19010322. Int J Mol Sci. 2018. PMID: 29361796 Free PMC article. Review.
-
Antiretroviral treatment of maternal HIV infection.Can Fam Physician. 2004 Jun;50:865-8. Can Fam Physician. 2004. PMID: 15233367 Free PMC article. Review.
-
Liver diseases in pregnancy: diseases unique to pregnancy.World J Gastroenterol. 2013 Nov 21;19(43):7639-46. doi: 10.3748/wjg.v19.i43.7639. World J Gastroenterol. 2013. PMID: 24282353 Free PMC article. Review.
-
Sex differences in antiretroviral therapy-associated intolerance and adverse events.Drug Saf. 2005;28(12):1075-83. doi: 10.2165/00002018-200528120-00003. Drug Saf. 2005. PMID: 16329711 Review.
-
Acute Fatty Liver Disease of Pregnancy: Updates in Pathogenesis, Diagnosis, and Management.Am J Gastroenterol. 2017 Jun;112(6):838-846. doi: 10.1038/ajg.2017.54. Epub 2017 Mar 14. Am J Gastroenterol. 2017. PMID: 28291236 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
